SCHEMBL4026288

SCHEMBL4026288

CC(=O)Nc1c(N)ccc2cnccc12

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IMPDH2 P12268 6/20 0.49
LMNA P02545 1/20 0.44
CYP1A2 P05177 1/20 0.44
CYP3A4 P08684 1/20 0.44
CYP2D6 P10635 1/20 0.44
CYP2C9 P11712 1/20 0.44
CYP2C19 P33261 1/20 0.44
ERN1 O75460 1/20 0.42
KDM4E B2RXH2 2/20 0.40
ALDH1A1 P00352 1/20 0.40
GLA P06280 1/20 0.40
GAA P10253 1/20 0.40
EP300 Q09472 1/20 0.39
KAT2B Q92831 1/20 0.39
KAT8 Q9H7Z6 1/20 0.39
MAPK10 P53779 1/20 0.39
MAPT P10636 1/20 0.39
GALK1 P51570 1/20 0.39
ATM Q13315 1/20 0.39
TRPV1 Q8NER1 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4024851 0.77 MAPT (0.43) LMNACYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL4021056 0.74 EP300 (0.51) LMNACYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL4023574 0.72 MAPT (0.62) LMNAKDM4EALDH1A1MAPTGALK1
SCHEMBL4019913 0.72 CHUK (0.45) KDM4EALDH1A1MAPK10MAPTGALK1
SCHEMBL14357917 0.70 HDAC1 (0.46) KDM4EALDH1A1GLAGAAMAPT
SCHEMBL9426430 0.70 KDM4E (0.50) KDM4EALDH1A1GLAGAAMAPT
SCHEMBL12192639 0.70 IKBKB (0.46) CHUK
Acetone SCHEMBL27493038 0.70 IMPDH2 (0.45) IMPDH2LMNACYP1A2CYP3A4CYP2D6
SCHEMBL11741231 0.70 MAPK10 (0.47) IMPDH2CYP1A2MAPK10MAPTTRPV1
SCHEMBL7843617 0.70 IMPDH2 (0.61) IMPDH2LMNACYP1A2CYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1478363-B1 FUSED AZABICYCLIC COMPOUNDS THAT INHIBIT VANILLOID RECEPTOR SUBTYPE 1 (VR1) RECEPTOR ABBOTT LAB (US) 2009-01-14 EP claimed
EP-1478363-B1 FUSED AZABICYCLIC COMPOUNDS THAT INHIBIT VANILLOID RECEPTOR SUBTYPE 1 (VR1) RECEPTOR ABBOTT LAB (US) 2009-01-14 EP disclosed